Design and implementation of the North American Pediatric Cardiomyopathy Registry

M A Grenier1, S K Osganian, G F Cox

  • 1Children's Hospital at Strong, University of Rochester, NY, USA.

American Heart Journal
|January 29, 2000
PubMed

Insights

The Pediatric Cardiomyopathy Registry (PCMR) established a large database for pediatric cardiomyopathy, collecting data on children with the condition. This registry aims to improve understanding of the disease

Area of Science:

  • Pediatric Cardiology
  • Epidemiology
  • Clinical Research

Background:

  • Pediatric cardiomyopathy presents significant health challenges in individuals under 18.
  • Limited data exists on the epidemiology and clinical course of pediatric cardiomyopathies.
  • Developing targeted treatments requires a better understanding of disease etiology and natural history.

Purpose of the Study:

  • To establish the Pediatric Cardiomyopathy Registry (PCMR) for children aged 18 years or younger.
  • To describe the epidemiologic features and clinical course of pediatric cardiomyopathies.
  • To facilitate the development of etiology-specific treatments for pediatric cardiomyopathy.

Main Methods:

  • Recruited 61 private and institutional pediatric cardiomyopathy practices in the US and Canada.
  • Established a prospective, population-based cohort and a retrospective cohort (diagnosed 1991-1996).
  • Collected annual follow-up data on all participating patients.

Main Results:

  • As of June 1999, the PCMR included 337 prospectively identified and 990 retrospectively identified patients.
  • Demonstrated the feasibility of creating a large sociodemographic and clinical database for pediatric cardiomyopathy.
  • The registry successfully aggregated data from multiple clinical sites.

Conclusions:

  • The PCMR provides a robust platform for studying pediatric cardiomyopathy.
  • The registry will yield precise incidence estimates and enhance understanding of the disease's natural history.
  • This cooperative effort is crucial for advancing research and treatment of pediatric cardiomyopathy.

Related Concept Videos

Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiomyopathy VI: Nursing Management01:29

Cardiomyopathy VI: Nursing Management

Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...